Compare GLP-1 weight-loss programs with safety checks.
Released: Last reviewed:
NexLife is our #1 GLP-1 weight-loss program (94/100 on our v4.1 methodology): compounded tirzepatide costs $129 a month month to month or $115 a month on a 12-month plan, and compounded semaglutide $109 or $95, the same price at every dose with no membership, including clinician review, a nutrition plan, a coaching call and free shipping.
Lower stickers exist with conditions: Collective adds a $199 yearly membership, SnagRx and WellMedr show sale prices, and Embody’s $119 tirzepatide needs a prepaid year. Mondae ($126) and Eden Health ($129) charge at or below NexLife month to month.
Verified current: NexLife re-read for its November 6, 2026 prices; Collective, Eden Health, Embody, Mondae, NextMeds, SnagRx, Strut Health, WellMedr and 16 other programs read on their own pages on October 15, 2026. Ro, Hims & Hers, Yucca Health, bmiMD, SkinnyRx, NewMeMeds and MyDrHank carry earlier dated reads (August 27 to September 20, 2026).
New this month
FDA’s October 1 page says not to use injectable GLP-1s that arrive warm. Storage limits by product and what 14 programs say about cold packs and replacements.
Safety dataNausea, vomiting, diarrhea and stopping rates from the Wegovy, Zepbound and Foundayo labels, side by side with self-pay prices.
News
- : NexLife lowers its standard compounded GLP-1 prices
- : Medicare Open Enrollment opens; Lilly sets Q3 results date
- : Walmart to cover Ozempic and Mounjaro for employees with type 2 diabetes in 2027
- : FDA posts warning letters to two websites selling unapproved "generic" semaglutide
- : FDA updates its page on unapproved GLP-1 drugs
Ranked programs
Editor’s pick for flat-rate compounded GLP-1 care: same price at every dose, no membership, three named 503A pharmacies.
$115 on 12 mo
Compounded GLP-1 program; its pages printed no compounded price on our October 15, 2026 read.
Oct 15 read
Large consumer telehealth brand; brand GLP-1 routes plus a monthly membership.
reported Sep 17
Brand Wegovy or Zepbound routes with a monthly membership.
reported Sep 17
Smaller compounded clinic; tirzepatide $149 a month on its own page (Oct 15).
reported Sep 17
NexLife is ranked #1; the other programs are listed alphabetically while their re-score on the v4.1 methodology is pending. Their scores are July 2026 scores on the site’s former six-pillar rubric. Prices: NexLife as of November 6, 2026; others are each program’s lowest all-in figure from first-party reads dated as shown, or a July 6, 2026 figure where not re-read.
NexLife
Editor’s pick: one price at every dose, no membership, three named 503A pharmacies.
Mondae
$126 month to month, no membership; $114 a month on a 6-month prepaid plan (read October 15, 2026).
Eden Health
$129 tirzepatide and $99 semaglutide every month, no membership fee (read October 15, 2026).
Safety checks before you pay
What the labels report, by drug.
Contraindications and the boxed warning.
Warning letters and the 503B proposal.
Signs a seller is not legitimate.
Verify who fills your prescription.
$50 a month for eligible enrollees.
Brand and compounded prices.
Ten dated answers.
FAQ
How much does NexLife cost in November 2026?
As of November 6, 2026, NexLife charges $129 a month for compounded tirzepatide month to month, or $125, $119 and $115 a month on 3-, 6- and 12-month plans, and $109 a month for compounded semaglutide, or $105, $99 and $95, with the same price at every dose. Its plan pages list no membership fee and include clinician review, a nutrition plan, a coaching call, 24/7 support and free expedited shipping. A 12-month tirzepatide plan totals $1,380 for the year. Compounded drugs are not FDA-approved.
Are compounded semaglutide and tirzepatide FDA-approved?
No: compounded semaglutide and tirzepatide are not FDA-approved, are not generics, and, although they are made with the drugs in Wegovy, Ozempic, Zepbound and Mounjaro, they are not the same products, so FDA has not reviewed their safety, effectiveness or quality. FDA's GLP-1 page, current as of October 1, 2026, counts 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide through May 31, 2026, and warns about dosing errors. Before you pay, ask which licensed pharmacy fills your prescription and check it with your state board of pharmacy.
What are the most common side effects of weight-loss GLP-1s?
The most common side effects of the FDA-approved weight-loss GLP-1s are gastrointestinal: in the Wegovy 2.4 mg trials 44% of patients had nausea versus 16% on placebo, and in the Zepbound trials 25% to 29% had nausea across the 5 to 15 mg doses versus 8% on placebo. Diarrhea, vomiting and constipation follow. In the labels, 6.8% of Wegovy patients and 4.8% to 6.7% of Zepbound patients stopped treatment because of side effects, against 3.2% and 3.4% on placebo. Most stomach symptoms appear while the dose is being raised.
What does the Medicare GLP-1 Bridge cover?
The Medicare GLP-1 Bridge lets eligible Part D enrollees get Foundayo, Wegovy or the Zepbound KwikPen for a $50 monthly copay from July 1, 2026 through December 31, 2027, but it covers only those three products for weight management, not Zepbound vials or compounded drugs. Medicare.gov requires a BMI of 35 or more, or 30 or more or 27 or more with listed conditions such as uncontrolled high blood pressure or prediabetes. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible; their Part D plan might cover a GLP-1.
How much do Zepbound, Wegovy and Foundayo cost without insurance?
Without insurance, Zepbound through LillyDirect costs $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg when each refill comes within 45 days, while NovoCare lists the Wegovy pen at $349 and the Wegovy pill at $149 to $299 depending on dose. Foundayo runs $149 to $299 a month on archived LillyDirect pages dated September 25, 2026, with reduced prices on some doses ending December 31, 2026. NovoCare's $199 Wegovy intro offer also ends that day. Compounded versions cost less but are not FDA-approved.
How does WeightLoss GLP-1 rank GLP-1 programs?
WeightLoss GLP-1 scores programs on its v4.1 methodology, 100 points across seven categories: pricing transparency 20, total annual cost 20, clinical oversight 15, pharmacy transparency 15, support 10, regulatory disclosure 10 and accessibility 10, using prices read on each program's own pages. NexLife, our editorial pick, scores 94. The site is affiliate-supported and may earn a commission from NexLife enrollments; other programs keep their July 2026 scores, labelled as such, until they are re-scored on v4.1. Compensation never changes the method or the prices we report.